Skip to content
★ Sign in to follow
LS

Lowell Sears

Paratek Pharmaceuticals, Inc.Immunic, Inc.
Total declarations
4
Companies
2
▲ Purchases (2 ops.)
€128k
▼ Sales (0 ops.)
—

Latest filing published 09 Oct 2014 for Immunic, INC., €20k.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2
Positive at T+90
100%
Median T+90
+75.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 09 Oct 2014 · 4414 days ago · €20k
    -71.3%
    Entry US$6,400.00 · Close at T+365 US$1,836.00
  • Filed 23 Apr 2014 · 4583 days ago · €109k
    +131.2%
    Entry US$4,956.00 · Close at T+365 US$11,460.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Lowell Sears: trading record in brief

Lowell Sears discloses dealings in 2 companies, chiefly Immunic, Inc. and Paratek Pharmaceuticals, Inc. The record holds 4 filings, for trades running from 15 May 2006 to 8 October 2014.

The open-market record is one-sided, with 2 purchases worth €128k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2014: 2 purchases and no sales on the market.

On 9 October 2014 came the latest disclosure, an open-market purchase for €20k in Immunic, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Lowell Sears

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    DirectorExecutivesImmunic, Inc.
    25,008 USD0SEC
    1,429 shares@ US$17.50Common StockSEC:0001209191-14-062754:0
    Canonical exit: 6 Jan 2015 (T+90)
  • ●
    DirectorExecutivesImmunic, Inc.
    0SEC
    44,643 sharesCommon StockSEC:0001209191-14-028936:1
  • ▲
    DirectorExecutivesImmunic, Inc.
    150,000 USD0SEC
    12,500 shares@ US$12.00Common StockSEC:0001209191-14-028936:0
    Canonical exit: 22 Jul 2014 (T+90)
  • ●
    DirectorExecutivesParatek Pharmaceuticals, Inc.
    0SEC
    11,428 sharesCommon Stock, par value $0.001SEC:0001181431-06-030241:0

4 of 4 declarations